Position in JNJ
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$499,657,847
+$79,522,238 QoQ
Shares Held
2,044,092
+0.7% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50.18815200098625.ToString("F0")%
Shared 3.4397668989458405.ToString("F0")%
None 46.3720811000679.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $2,326,875,887 across 16 Drug Manufacturers - General names. JNJ ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,404,493 | $522,953,181 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,044,092 | $499,657,847 | |
| 3 | LLY |
ELI LILLY & Co
|
369,521 | $339,874,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,221,085 | $267,174,314 | |
| 5 | AZN |
Astrazeneca PLC
|
754,121 | $148,727,743 | |
| 6 | NVS |
Novartis AG
|
941,818 | $143,862,698 | |
| 7 | AMGN |
Amgen Inc
|
407,214 | $143,278,245 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,272,131 | $77,154,744 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $499,657,847 | 2,044,092 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $420,135,609 | 2,030,131 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $362,280,084 | 1,953,835 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $237,397,786 | 1,554,159 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $263,081,444 | 1,586,357 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $228,826,440 | 1,582,260 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $288,068,293 | 1,777,541 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $310,276,632 | 2,122,856 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $320,169,123 | 2,023,953 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $377,753,430 | 2,410,064 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $427,698,376 | 2,746,057 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $463,151,606 | 2,798,161 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $456,473,140 | 2,944,988 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $602,847,977 | 3,412,669 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $551,755,586 | 3,377,544 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $587,365,501 | 3,308,915 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $591,103,875 | 3,335,236 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $581,185,005 | 3,397,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $544,044,564 | 3,368,697 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $551,692,678 | 3,348,869 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $549,322,453 | 3,342,394 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $524,635,829 | 3,333,561 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $466,943,061 | 3,136,372 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $475,794,742 | 3,383,309 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $438,732,259 | 3,345,781 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||